Navigating the clinical impact of TROP2-targeting in NSCLC
touchSYMPOSIUM for touchRESPIRATORY
Listen to this touchSYMPOSIUM recorded live in March 2025 at the The European Lung Cancer Congress in Paris, France.
Symposium chair Prof. Marina Garassino is joined by Prof. Jarushka Naidoo and Prof. David Planchard to explore the evolving role of TROP2-targeted ADCs in NSCLC.
Session 1: Prof. Marina Garassino highlights the emergence of TROP2 in NSCLC as a promising area of therapeutic innovation
Session 2: Prof. Jaruska Naidoo discusses the latest clinical trial findings for TROP2-targeting ADCs in NSCLC
Session 3: Prof. David Planchard discusses the…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.